Oruka Therapeutics, Inc. logo ORKA - Oruka Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $153.25 DETAILS
HIGH: $200.00
LOW: $120.00
MEDIAN: $155.50
CONSENSUS: $153.25
UPSIDE: 79.67%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 46.9 3.9 0.5
Cost of Revenue 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0 0 2.3 3.2 57.8
Gross Profit (0.1) (0.0) (0.1) (0.1) (0.1) (0.1) (0.1) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (2.9) (0.3) 0 0 44.5 0.7 (57.2)
Operating Expenses
R&D Expenses 100.6 75.1 1.0 4.5 13.8 5.0 1.8 4.2 14.1 12.3 7.1 5.6 2.9 1.1 0 3.1 10.0 11.0 42.7 89.4 0
SG&A Expenses 21.3 13.0 6.2 5.3 5.4 4.7 3.9 3.9 4.6 4.2 4.4 4.1 4.0 3.2 4.4 5.7 12.4 8.2 18.4 27.4 15.8
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 24.5 0
Operating Expenses 122.0 88.1 7.2 9.7 19.2 9.7 5.7 8.1 18.7 16.6 11.4 9.7 6.9 4.3 4.4 8.8 22.4 19.3 61.1 141.3 15.8
Operating Income
Operating Income (122.1) (88.1) (7.3) (9.8) (19.3) (9.8) (5.8) (8.1) (18.7) (16.6) (11.5) (9.7) (6.9) (4.3) (7.4) (9.2) (22.9) (19.5) (16.6) (140.6) (73.0)
Interest Expense 0 1.5 0 0 0 0.0 0.0 0 0 0 0 0 0 0.0 0.0 0.0 0.2 0.2 0.1 0.6 1.0
Interest Income 16.6 5.9 2.0 0.7 0 0 0 0 0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.2 6.7 8.4 2.4
Profitability
EBITDA (105.3) (82.2) (5.2) (9.8) (19.2) (9.6) (5.6) (7.9) (18.5) (16.4) (11.4) (9.7) (6.9) (4.3) (4.8) (8.1) (10.8) (19.0) (9.9) (129.0) (67.7)
EBIT (105.4) (82.3) (5.3) (9.9) (19.3) (9.7) (5.6) (8.0) (18.6) (16.4) (11.4) (9.7) (6.9) (4.3) (5.4) (8.4) (11.2) (19.3) (12.2) (132.2) (70.3)
Income Before Tax (105.4) (83.7) (5.3) (9.9) (19.3) (9.7) (5.6) (8.0) (18.6) (16.4) (11.4) (9.7) (6.9) (4.3) (5.4) (8.4) (11.4) (19.4) (12.3) (132.8) (71.6)
Income Tax Expense 0 0 0 0 0 (0.0) (0.2) (0.0) (0.1) 0 0 0 0 0 0 0 (2.3) 0 0 0 0
Net Income (105.4) (83.7) (5.3) (9.9) (19.3) (9.7) (5.5) (7.9) (18.5) (16.4) (11.4) (9.7) (6.9) (4.3) (5.4) (8.4) (9.1) (19.4) (12.3) (132.8) (71.6)
Per Share Data
EPS (Basic) -2.31 -4.99 -4.44 -8.27 -16.68 -8.40 -49.79 -123.73 -382.87 -390.96 -393.12 -710.64 -1572.48 -2933.25 -4808.16 -8981.28 -12882.00 -4666636.00 -41731.00 -468115.00 -313891.00
EPS (Diluted) -2.31 -4.99 -4.44 -8.27 -16.68 -8.40 -49.79 -123.73 -382.87 -390.96 -393.12 -710.64 -1572.48 -2933.25 -4808.16 -8981.28 -12882.00 -4666636.00 -41731.00 -468115.00 -313891.00
Shares Outstanding 45.6 16.8 14.4 14.4 13.9 4.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Current Assets
Cash & Cash Equivalents 46.9 61.6 37.4 42.4 53.4 49.1 8.4 6.6 8.7 7.4 38.8 15.4 16.8 2.9 5.9 7.0 7.8 7.7 32.1 60.3 37.8
Short-Term Investments 290.1 314.1 0 0 0 0 0 0 3.0 13.8 0 0 0 0 0 0 0 0 65.5 92.8 32.6
Net Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 8.6 1.2
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 6.8 1.2 0.2 0.3 1.1 0.9 0.1 0.2 0.5 0.3 0.1 0.1 0.2 0.1 0.3 0.1 0.5 1.9 1.8 4.7 2.0
Total Current Assets 343.9 376.9 37.6 42.7 54.4 50.0 8.5 6.8 12.3 21.4 38.9 15.5 16.9 3.0 6.2 7.2 8.3 9.7 100.0 166.3 85.8
Non-Current Assets
Property, Plant & Equipment 2.1 1.0 0.3 0.4 0.5 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 1.0 1.3 8.9 12.0 15.2
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.7 4.7 4.7
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 142.5 18.1 0 0 0 0 0 0 0 2.4 0 0 0 0 0 0 0 0 6 0 0
Other Non-Current Assets 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.6 0.1 0.1 0.2 0.3 0.1 0.1 1.1 1.4 2.4
Total Non-Current Assets 144.8 19.1 0.3 0.4 0.5 0.5 0.1 0.0 0.1 3.2 0.7 0.6 0.2 0.2 0.3 1.0 1.1 1.4 20.7 18.1 22.3
Total Assets 488.6 396.0 37.9 43.1 54.9 50.4 8.5 6.8 12.4 24.6 39.6 16.1 17.1 3.2 6.5 8.2 9.4 11.1 120.7 184.4 108.0
Current Liabilities
Account Payables 4.2 3.5 0 0.3 1.1 1.8 0.4 0.2 0.6 0 0 0 0.6 0.1 0.3 0.4 0.5 0.8 2.8 7.0 4.9
Short-Term Debt 0.6 0.2 0.1 0.1 0.1 0.0 0.0 0 0 0 0 0 0 0 0 0 0 12.3 0 3.7 8.3
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0 0 0 0 0
Other Current Liabilities 5.3 7.3 0.5 0.5 1.4 0.9 0.4 0.4 0.7 1.7 0.8 1.1 0.4 0.1 0.3 0.6 0.9 1.7 13.1 30.1 20.7
Total Current Liabilities 15.4 13.0 0.6 1.1 3.5 3.5 0.9 0.8 2.1 2.4 1.5 1.4 1.5 0.3 0.8 1.2 1.6 15.8 18.2 43.8 36.2
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1 3.8
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0.0 0.0 0 0 0 0 0 0 0 0.1 13.2 0.1 0.4
Total Non-Current Liabilities 1.3 0.8 0.2 0.3 0.4 0.4 0 0 0.0 0.0 0 0.0 0.0 0 0.0 0.2 0.3 0.6 34.8 70.7 15.1
Total Liabilities 16.7 13.8 0.8 1.4 3.9 3.9 0.9 0.8 2.1 2.4 1.5 1.4 1.5 0.3 0.8 1.4 2.0 16.4 53.0 114.6 51.3
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0
Retained Earnings (189.2) (83.7) (188.7) (183.4) (173.5) (154.2) (144.4) (138.9) (131.0) (112.5) (96.1) (84.6) (74.9) (68.0) (63.7) (58.3) (49.9) (40.8) (470.5) (458.2) (327.7)
Accumulated Other Comprehensive Income 0.5 (0.0) 0 0 0 0 0 0 (0.0) (0.0) 0 0 0 0 0 0 0 0 0.0 0.0 (0.2)
Total Stockholders' Equity 471.9 382.2 37.0 41.7 51.0 46.5 7.6 6.0 10.3 22.2 38.1 14.7 15.6 2.9 5.7 6.8 7.4 (5.3) 67.7 69.8 56.8
Total Liabilities & Equity 488.6 396.0 37.9 43.1 54.9 50.4 8.5 6.8 12.4 24.6 39.6 16.1 17.1 3.2 6.5 8.2 9.4 11.1 120.7 184.4 108.0
Debt Metrics
Total Debt 1.9 1.0 0.3 0.4 0.5 0.5 0.0 0 0 0 0 0 0 0 0 0 0 12.3 0 22.7 12.1
Net Debt (45.0) (60.6) (37.2) (42.1) (52.9) (48.6) (8.3) (6.6) (8.7) (7.4) (38.8) (15.4) (16.8) (2.9) (5.9) (7.0) (7.8) 4.6 (32.1) (37.6) (25.7)
Metric 2025 2024 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Operating Activities
Net Income (105.4) (83.7) (9.9) (19.3) (9.7) (5.5) (7.9) (18.5) (16.4) (11.4) (9.7) (6.9) (4.3) (5.4) (8.4) (9.1) (19.4) (12.3) (132.8) (71.6)
Depreciation & Amortization 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.5 0.2 2.3 3.2 2.7
Stock-Based Compensation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Change in Working Capital (2.6) 11.6 (1.7) (0.0) 1.9 0.4 (0.6) 0.1 0.4 0.1 (0.4) 1.3 (0.1) (0.5) (0.4) (13.1) 0.1 (48.6) 53.8 9.9
Other Non-Cash Items 19.7 14.3 0.6 0.5 0.0 0.2 0.3 0.9 1.0 0.8 0.7 0.3 0.3 (1.7) 0.2 (17.6) 0.7 12.6 38.8 (0.0)
Operating Cash Flow (88.2) (57.8) (10.9) (18.8) (7.7) (4.8) (8.2) (17.5) (15.0) (10.5) (9.4) (5.3) (4.1) (7.0) (8.3) (41.7) (18.4) (46.0) (37.1) (59.0)
Investing Activities
Capital Expenditure (0.2) (0.2) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) 0 (0.0) (0.0) (0.2) (1.3) (0.4) (2.4) (2.6)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0.3 0.0 0.1 0.5 0
Purchases of Investments (521.0) (329.9) 0 0 0 0 0 (5.5) (20.5) 0 0 0 0 0 0 0 0 (116.6) (114.6) (62.8)
Sales/Maturities of Investments 424.4 0 0 0 0 0 3.0 18.4 4.1 0 0 0 0 0 0.3 45.5 0 143.9 54.4 64.2
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0 0 2.0 0 0 (1.2) (6) 0 0
Investing Cash Flow (96.7) (330.1) (0.0) (0.0) (0.0) (0.0) 3.0 12.9 (16.4) (0.0) (0.0) (0.0) 0 2.0 0.3 45.6 (2.5) 21.1 (62.1) (1.2)
Financing Activities
Net Debt Issuance 0 0 0 0 (0.4) (0.3) 0 0 0 0 0 (0.2) (0.1) 0 0 (4) 12.8 (3.8) (5.6) (3.4)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0 0 (0.3) (0.3) 0 (0.2) (0.2) 0 0 (0.1) (0.3) 0 0 0 (2.8) 0.2
Financing Cash Flow 170.3 449.5 0 23.1 48.5 6.6 3.1 5.8 0 34.0 8.0 19.2 1.1 3.9 7.3 (3.9) 12.8 (3.4) 121.7 81.2
Cash Position
Net Change in Cash (14.6) 24.1 (10.9) 4.3 40.7 1.8 (2.1) 1.3 (31.4) 23.4 (1.4) 13.8 (3.0) (1.1) (0.7) 0.0 (24.3) (28.3) 22.6 37.8
Cash at Beginning 61.6 37.4 53.4 49.1 8.4 6.6 8.7 7.4 38.8 15.4 16.8 2.9 5.9 7.0 7.8 7.7 32.1 60.3 37.8 0
Cash at End 46.9 61.6 42.4 53.4 49.1 8.4 6.6 8.7 7.4 38.8 15.4 16.8 2.9 5.9 7.0 7.8 7.7 32.1 60.3 37.8
Free Cash Flow (88.4) (58.0) (10.9) (18.8) (7.7) (4.8) (8.2) (17.5) (15.0) (10.5) (9.4) (5.3) (4.1) (7.0) (8.3) (41.9) (19.7) (46.3) (39.5) (61.6)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 46.9 3.9 0.5
Gross Profit (0.1) (0.0) (0.1) (0.1) (0.1) (0.1) (0.1) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (2.9) (0.3) 0 0 44.5 0.7 (57.2)
Operating Income (122.1) (88.1) (7.3) (9.8) (19.3) (9.8) (5.8) (8.1) (18.7) (16.6) (11.5) (9.7) (6.9) (4.3) (7.4) (9.2) (22.9) (19.5) (16.6) (140.6) (73.0)
Net Income (105.4) (83.7) (5.3) (9.9) (19.3) (9.7) (5.5) (7.9) (18.5) (16.4) (11.4) (9.7) (6.9) (4.3) (5.4) (8.4) (9.1) (19.4) (12.3) (132.8) (71.6)
EPS (Diluted) -2.31 -4.99 -4.44 -8.27 -16.68 -8.40 -49.79 -123.73 -382.87 -390.96 -393.12 -710.64 -1572.48 -2933.25 -4808.16 -8981.28 -12882.00 -4666636.00 -41731.00 -468115.00 -313891.00
Balance Sheet
Cash & Equivalents 46.9 61.6 37.4 42.4 53.4 49.1 8.4 6.6 8.7 7.4 38.8 15.4 16.8 2.9 5.9 7.0 7.8 7.7 32.1 60.3 37.8
Total Assets 488.6 396.0 37.9 43.1 54.9 50.4 8.5 6.8 12.4 24.6 39.6 16.1 17.1 3.2 6.5 8.2 9.4 11.1 120.7 184.4 108.0
Total Debt 1.9 1.0 0.3 0.4 0.5 0.5 0.0 0 0 0 0 0 0 0 0 0 0 12.3 0 22.7 12.1
Stockholders' Equity 471.9 382.2 37.0 41.7 51.0 46.5 7.6 6.0 10.3 22.2 38.1 14.7 15.6 2.9 5.7 6.8 7.4 (5.3) 67.7 69.8 56.8
Cash Flow
Operating Cash Flow (88.2) (57.8) (10.9) (18.8) (7.7) (4.8) (8.2) (17.5) (15.0) (10.5) (9.4) (5.3) (4.1) (7.0) (8.3) (41.7) (18.4) (46.0) (37.1) (59.0)
Capital Expenditure (0.2) (0.2) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) 0 (0.0) (0.0) (0.2) (1.3) (0.4) (2.4) (2.6)
Free Cash Flow (88.4) (58.0) (10.9) (18.8) (7.7) (4.8) (8.2) (17.5) (15.0) (10.5) (9.4) (5.3) (4.1) (7.0) (8.3) (41.9) (19.7) (46.3) (39.5) (61.6)